Anna Charlene Cowan, APRN | |
230 E Marydale Ave, Soldotna, AK 99669 | |
(907) 262-3119 | |
Not Available |
Full Name | Anna Charlene Cowan |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Psychiatric/mental Health |
Location | 230 E Marydale Ave, Soldotna, Alaska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255037404 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 202439 (Alaska) | Primary |
Entity Name | Nurses Diversified Systems, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972873784 PECOS PAC ID: 7517127996 Enrollment ID: O20120321000698 |
News Archive
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
Scientists from the University of Granada, Spain, have generated artificial human skin by tissular engineering basing on agarose-fibrin biomaterial. The artificial skin was grafted onto mice, and optimal development, maturation and functionality results were obtained.
Some welcome news at the height of summer swimming season: Children are far less likely to drown in California than they were in the 1980s — and child drowning rates have continued to fall even in the past decade, according to data from the Centers for Disease Control and Prevention.
U-Systems, the leader in automated breast ultrasound today announced the completion of a pivotal ROC Reader Study for automated breast ultrasound cancer screening. Conducted by University of Chicago, an acclaimed pioneer in women's heath research, the multi-reader, multi-case (MRMC) ROC Reader Study was carried-out to evaluate the sensitivity of somo•v™ Automated Breast Ultrasound (ABUS) together with a screening mammogram in detecting breast cancer in women with dense breast tissue.
Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Anna Charlene Cowan, APRN 230 E Marydale Ave, Soldotna, AK 99669 Ph: (907) 262-3119 | Anna Charlene Cowan, APRN 230 E Marydale Ave, Soldotna, AK 99669 Ph: (907) 262-3119 |
News Archive
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
Scientists from the University of Granada, Spain, have generated artificial human skin by tissular engineering basing on agarose-fibrin biomaterial. The artificial skin was grafted onto mice, and optimal development, maturation and functionality results were obtained.
Some welcome news at the height of summer swimming season: Children are far less likely to drown in California than they were in the 1980s — and child drowning rates have continued to fall even in the past decade, according to data from the Centers for Disease Control and Prevention.
U-Systems, the leader in automated breast ultrasound today announced the completion of a pivotal ROC Reader Study for automated breast ultrasound cancer screening. Conducted by University of Chicago, an acclaimed pioneer in women's heath research, the multi-reader, multi-case (MRMC) ROC Reader Study was carried-out to evaluate the sensitivity of somo•v™ Automated Breast Ultrasound (ABUS) together with a screening mammogram in detecting breast cancer in women with dense breast tissue.
Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older.
› Verified 4 days ago
Aubrey Woodford, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 44604 Sterling Hwy Ste D, Soldotna, AK 99669 Phone: 907-420-0585 Fax: 907-420-0586 | |
Ms. Barbara A Hagie, ANP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 250 Hospital Place, Pain Management Clinic, Soldotna, AK 99669 Phone: 907-714-4075 | |
Barbara Ransom, A.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 230 E Marydale Ave, Suite 2, Soldotna, AK 99669 Phone: 907-260-3691 Fax: 907-260-7301 | |
Mr. Jeoffrey Walter Lanfear, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 44604 Sterling Hwy Ste D, Soldotna, AK 99669 Phone: 907-420-0585 Fax: 907-420-0586 | |
Ms. Kathryn A Flores, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 245 N Binkley St Ste 202, Soldotna, AK 99669 Phone: 907-714-4521 | |
Dana Lynn Oswald, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 240 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4502 Fax: 907-714-4916 | |
Steven L Smalling, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 265 N Binkley St, Soldotna, AK 99669 Phone: 907-262-9341 Fax: 907-262-1545 |